BioNTech SE (BNTX) Financials

BNTX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 23.2 billion 2.9 billion
March 31, 2026 24.2 billion 2.7 billion
Dec. 31, 2025 25.8 billion 3.2 billion
Sept. 30, 2025 25.0 billion 3.4 billion

BNTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -51.1 million 23.9 million
March 31, 2026 -556.5 million 26.1 million
Dec. 31, 2025 279.0 million 28.3 million
Sept. 30, 2025 951.9 million 32.7 million

BNTX Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -952.3 million
March 31, 2026 -619.6 million
Dec. 31, 2025 -354.7 million
Sept. 30, 2025 -39.4 million

BNTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 11.1 billion 295.4 million -
March 31, 2026 16.8 billion - 282.3 million
Dec. 31, 2025 17.4 billion 35.1 million 217.4 million
Sept. 30, 2025 17.0 billion 29.6 million 242.9 million

BNTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 289.1 million
March 31, 2026 289.8 million
Dec. 31, 2025 287.8 million
Sept. 30, 2025 280.7 million

BNTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 63.7 million 639.3 million 33.3 million 45.8 million
March 31, 2026 66.2 million 648.8 million 172.8 million 32.0 million
Dec. 31, 2025 72.2 million 587.8 million 342.4 million 57.9 million
Sept. 30, 2025 51.0 million 662.8 million 174.3 million 32.0 million

BNTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 122.5 million 308.7 million
March 31, 2026 137.6 million 224.5 million
Dec. 31, 2025 1.1 billion 387.6 million
Sept. 30, 2025 1.8 billion 174.0 million

BNTX

Price: $96.96

52 week price:
79.52
124.00

Payout Ratio Range:
0.43%
28.97%

Earnings Per Share: -7.68 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 379200

Market Capitalization: 24.0 billion

Links: